March 06, 2023 09:00 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP-mediated nucleic acid-based immunotherapy announced today that ...
The article "Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic," authored by our academic collaborator, Dr. Duane Mitchell was released in AACR's journal of Clinical Cancer Research on March ...
38th Annual Meeting & Pre-Conference Programs (SITC 2023) Explore comprehensive resources and educational opportunities for cancer patients and those who advocate for them. Track the latest advancements and educational opportunities in ...
This meeting will feature in-person presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, ...
The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Innovative programming around the current and future ...
Join fellow oncology professionals at the 2023 ASCO Annual Meeting – a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care. Join ...
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances ...
For the past 23 years, the World Vaccine Congress Washington has evolved and grown into the leading vaccines congress globally, with hundreds of speakers, thousands of attendees and hundreds of networking opportunities. Our event ...
About Vaccines Summit Boston 2023 22-24 May, 2023 Following the tremendous response for Vaccines Summit Ohio 2021 and Vaccines Summit Boston 2022, Biogate Scientific Center brings to you the 3rd ...
ReMission Summit, March 25-26, 2023 WE’RE HERE TO REWRITE THE STORY OF BRAIN CANCER. LET’S EMPOWER PATIENTS TO TAKE THEIR LIVES BACK. It’s year four in our mission to lead ...
January 04, 2023 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP-mediated nucleic acid-based immunotherapy, announced today that ...